Determining the precise bacteriostatic water volume for reconstituting CJC-1295 and Ipamorelin research compounds is vital for maintaining peptide stability and accurate micro-molar concentrations in laboratory bioassays. This technical reference details reconstitution calculations, Drug Affinity Complex (DAC) bioconjugation mechanics, and analytical standards for somatotropic axis research.
Determining the precise bacteriostatic water volume for reconstituting CJC-1295 and Ipamorelin research compounds is vital for maintaining peptide stability and accurate micro-molar concentrations in laboratory bioassays. This technical reference details reconstitution calculations, Drug Affinity Complex (DAC) bioconjugation mechanics, and analytical standards for somatotropic axis research.
To achieve a standard laboratory concentration when preparing a cjc 1295 ipamorelin bacteriostatic water mix, investigators typically add 2.0 mL to 3.0 mL of bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) to a 5 mg or 10 mg lyophilized peptide vial. For a combined 5 mg/5 mg blend vial, adding 2.5 mL of diluent yields a working concentration of 2,000 mcg (2 mg) total peptide per mL, or 100 mcg per 0.05 mL (5 units on a standard U-100 micro-syringe).
Selecting the exact diluent volume depends on the required assay target concentration and pipetting precision. Reconstituting with 2.0 mL of bacteriostatic water into a 5 mg vial yields 2.5 mg/mL (250 mcg per 0.1 mL), whereas 5.0 mL of diluent yields a lower concentration of 1.0 mg/mL (100 mcg per 0.1 mL). High-precision analytical experiments evaluating receptor binding kinetics often utilize smaller reconstituting volumes to avoid excessive volumetric error during micro-aliquoting.
Researchers evaluating dual-action GH secretagogue profiles can source verified purity compounds such as the CJC-1295 Ipamorelin Blend alongside dedicated Bacteriostatic Water for standardized laboratory preparation.
In vitro and preclinical research demanding high reproducibility requires strict analytical verification of all lyophilized peptides and reconstituting solvents. Impurities or bacterial endotoxins can confound somatotroph secretion assays and alter receptor affinity measurements.
PX1 Research maintains rigorous quality control frameworks across all research peptides to ensure reproducible assay conditions:
Understanding the structural modification of CJC-1295 requires examining how the Drug Affinity Complex (DAC) alters pharmacokinetic properties. As illustrated in a standard "drug affinity complex" "cjc-1295" diagram, the DAC moiety consists of a reactive N-epsilon-3-(maleimido-propionyl) lysine linker attached to the C-terminus of the 29-amino-acid Growth Hormone Releasing Hormone (GHRH) sequence.
Upon reconstitution and introduction to biological fluids in ex vivo or in vivo models, the maleimide group covalently binds specifically to the Cys34 residue of endogenous serum albumin. This bioconjugation shields the peptide from rapid enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV), dramatically extending its biological half-life from minutes to several days.
In contrast, CJC-1295 No DAC (also known as Modified GRF 1-29) lacks this reactive linker. While both compounds act as GHRH analogs to stimulate somatotroph cells in the anterior pituitary, CJC-1295 No DAC exhibits a rapid plasma clearance curve, mimicking natural pulsatile GHRH release. Research groups studying prolonged baseline IGF-1 elevation often select CJC-1295 DAC, whereas those investigating natural secretory dynamics utilize CJC-1295 No DAC.
Preclinical studies demonstrate that co-administering a GHRH analog with a Growth Hormone Secretagogue Receptor (GHSR) agonist produces a synergistic—rather than additive—release of growth hormone. CJC-1295 binds directly to the GHRH receptor (GHRHR) on pituitary somatotrophs, activating the adenylate cyclase pathway and elevating intracellular cyclic AMP (cAMP).
Concurrently, Ipamorelin functions as a selective ghrelin receptor agonist. It binds to the GHSR-1a receptor, triggering an intracellular inositol trisphosphate (IP3) signaling cascade that releases calcium ions from the endoplasmic reticulum. When both pathways are activated simultaneously, the intracellular signal crosstalk leads to a amplified exocytosis of stored GH granules.
Crucially, in vitro data indicate that Ipamorelin maintains extreme receptor selectivity, omitting activation of cortisol, ACTH, or prolactin secretion pathways even at high nanomolar concentrations. This makes the combination ideal for isolated pituitary axis signaling studies.
Selecting the appropriate secretagogue for laboratory research requires evaluating receptor affinity, half-life, and pathway selectivity. Within the somatotropic research class, several compounds offer distinct operational profiles.
While CJC-1295 provides sustained GHRH receptor occupancy, Sermorelin represents the native truncated 29-amino-acid chain of GHRH with a very brief half-life (~10-12 minutes). Tesamorelin incorporates a hexenoyl moiety to enhance metabolic stability while focusing heavily on lipolytic pathways in metabolic models. On the GHSR agonist side, GHRP-2 offers potent GH release but displays moderate cross-reactivity with cortisol pathways, whereas Ipamorelin provides targeted GHSR-1a activation with minimal secondary endocrine disturbance.
Researchers seeking complete access to these compounds can browse the full range of options in the PX1 all peptides catalog or consult the comprehensive research hub for comparative molecular datasets.
Reconstituting lyophilized CJC-1295 and Ipamorelin requires meticulous aseptic technique to prevent bacterial contamination and structural peptide shearing.
1. **Equilibration:** Allow the lyophilized vial and bacteriostatic water to reach room temperature (20°C–25°C) prior to fluid introduction to reduce thermal stress on the peptide lattice. 2. **Sanitization:** Swab the rubber stoppers of both vials using 70% isopropyl alcohol wipes and allow them to air dry fully. 3. **Volume Extraction:** Using a sterile laboratory syringe, draw the calculated volume of bacteriostatic water (e.g., 2.5 mL for a 5 mg blend vial). 4. **Controlled Injection:** Aim the needle against the glass inner wall of the peptide vial. Directing the stream against the wall allows the diluent to slowly cascade over the cake, preventing mechanical disruption of delicate peptide chains. 5. **Solubilization:** Gently swirl the vial in a smooth circular motion. Never shake the vial, as violent agitation introduces air bubbles and promotes peptide aggregation or denaturation.
Once fully dissolved, inspect the solution under direct light. The resulting mixture should be crystal clear and completely free of particulate matter before use in analytical assays.
The solubility of CJC-1295 and Ipamorelin is strongly dependent on solvent pH and ionic strength. Bacteriostatic water formulated with 0.9% benzyl alcohol maintains a slightly acidic pH (4.5–7.0), which preserves the protonation state of basic amino acid residues (such as lysine and arginine) and maintains solubility.
If an assay requires reconstitution in phosphate-buffered saline (PBS) or cell culture media, researchers must monitor for potential precipitation. At neutral to slightly alkaline pH, hydrophobic interactions can accelerate peptide self-assembly into insoluble fibrils. For long-term liquid stability in non-preserved media, maintaining an acidic micro-environment (pH 4.0–6.0) is recommended prior to final assay dilution.
For bulk assay requirements or specialized research protocols, institutional buyers can establish custom supply parameters via PX1 wholesale services.
Lyophilized CJC-1295 and Ipamorelin display high stability when stored under desiccated conditions at -20°C to -80°C, remaining viable for up to 24 months. Upon reconstitution with bacteriostatic water containing 0.9% benzyl alcohol, the solution remains stable at 2°C to 8°C for approximately 28 to 30 days.
Primary degradation pathways for CJC-1295 and Ipamorelin in aqueous solution include deamidation of asparagine residues, oxidation of methionine, and peptide chain cleavage. Exposure to UV light and repeated room-temperature thermal cycling drastically accelerates these chemical breakdowns.
To maximize trial consistency, store reconstituted vials in a dedicated laboratory refrigerator away from freezer frost-free cycling zones. Detailed degradation kinetics and storage guidelines for various GHRH peptides are available in our GHRH analogs mechanism article.
What is the correct cjc 1295 ipamorelin bacteriostatic water mix ratio?
The standard laboratory reconstitution ratio is 2.0 mL to 3.0 mL of bacteriostatic water per 5 mg or 10 mg combined vial. For instance, adding 2.5 mL to a 5 mg CJC-1295 / Ipamorelin vial provides a concentration of 2,000 mcg/mL (100 mcg per 0.05 mL volume).
How does the "drug affinity complex" "cjc-1295" diagram illustrate serum albumin binding?
A Drug Affinity Complex (DAC) diagram illustrates the maleimide group at the C-terminus of CJC-1295 forming a covalent thioether bond with the Cys34 residue of endogenous serum albumin. This conjugation protects the peptide from DPP-IV enzymatic cleavage, extending its biological half-life in research models.
What is the difference between CJC-1295 with DAC and CJC-1295 No DAC?
CJC-1295 with DAC contains a maleimide reactive group that binds albumin to extend plasma half-life to several days, sustaining baseline GH levels. CJC-1295 No DAC lacks this complex, clearing within hours and triggering brief, pulsatile spikes in growth hormone release.
Why is bacteriostatic water preferred over sterile water for peptide reconstitution?
Bacteriostatic water contains 0.9% benzyl alcohol, which acts as a bacteriostatic preservative to inhibit microbial growth. This allows for repeated sampling from the vial over a 28-day period, whereas plain sterile water lacks preservatives and must be used immediately.
How should reconstituted CJC-1295 and Ipamorelin be stored in the lab?
Once reconstituted, vials must be stored in a laboratory refrigerator at 2°C to 8°C (36°F to 46°F), protected from light. They should not be repeatedly frozen and thawed after solubilization.
Can CJC-1295 and Ipamorelin be reconstituted together in the same vial?
Yes, premixed lyophilized vials containing both CJC-1295 and Ipamorelin are routinely reconstituted using a single volume of bacteriostatic water, provided both compounds exhibit mutual solubility within the chosen pH range.
What analytical methods verify the purity of PX1 research peptides?
PX1 Research verifies compounds using High-Performance Liquid Chromatography (RP-HPLC) for purity (≥98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight and structural identity.
What is the endotoxin limit for PX1 CJC-1295 and Ipamorelin?
PX1 research compounds undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.01 EU/mg, preventing cell culture contamination and unwanted inflammatory signaling in assays.
How do I calculate precise micro-molar concentrations after reconstitution?
To calculate molarity, divide the reconstituted concentration in grams per liter by the molecular weight of the peptide. Detailed mathematical workflows are outlined in our [peptide reconstitution calculator guide](/research-peptides/peptide-reconstitution-calculator-guide).
How can I obtain a lot-specific Certificate of Analysis (COA)?
PX1 Research provides lot-specific COAs featuring complete HPLC chromatograms and mass spectra for every order. These can be downloaded directly from the product page or requested through our customer support team.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.